REDEFINING HEALTHCARE STANDARDS
OUR STORY
Cervital® combine 30+ years of expertise in colposcopy with more than 2×20 years of experience in launching startups
Cervital® was envisioned by Professor Joseph Monsonego, a renowned worldwide expert in papillomavirus infections and related cancers. With decades of clinical experience and a database of over 60,000 cases – with historical data and imaging data available for each consultation for over 20 years – he developed an AI model for real-time prediction of cervical precancers and cancers. This model, validated by international research, enhances diagnostic accuracy and clinical decision-making.
Traditional cervical cancer diagnosis relies on subjective visual assessments. Cervital addresses this by providing a reliable, objective tool. Collaborations with researchers from École Polytechnique and McGill University optimized the model’s performance.

Dr. Joseph
Monsonego
Led by Joseph serving as Chief Medical Officer, Cervital aims to revolutionize early detection and management of cervical cancers through AI. With an international network of clinical evaluators, Cervital® is committed to improving diagnostics and contributing to the elimination of cervical cancer, aligning with WHO goals. This innovative approach combines clinical expertise and technology for more predictive, preventive, and accessible healthcare.